Active Ingredient(s): Ponesimod
FDA Approved: * March 18, 2021
Pharm Company: * JANSSEN PHARMS
Category: Multiple Sclerosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ponvory Overview

Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis (MS).[1][4] The most common side effects include upper respiratory tract infection, hepatic transaminase elevation, and hypertension.[1][4] Ponesimod was approved for medical use in the United States in March 2021[1][4] and in the European Union in June 2021.[5] Contents 1 Clinica...

Read more Ponvory Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ponesimod

Recent Ponvory Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 10mg, 20mg, 2mg, 3mg, 4mg, 5mg, 6mg, 7mg, 8mg, 9mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ponvory: (2 results)

Sorted by National Drug Code
  • 50458-707 PonvoryPonvory Kit by Janssen Pharmaceuticals, Inc
  • 50458-720 Ponvory 20 mg Oral Tablet, Film Coated by Janssen Pharmaceuticals, Inc

Other drugs which contain Ponesimod or a similar ingredient: (1 result)